Vivita Technologies is an emerging tissue engineering and regenerative medicine market. The resulting biomaterial is immune-compatible for use in human patients and serves as a blueprint for regeneration in the body. They intend to use this technology to create off-the-shelf tissue and organ replacements that avoid long-term medication, repeat